Targets › CYP51
2 programs from 1 company in 2 trials: 2 Phase 4; Infectious disease.
Sterol 14alpha-demethylase that plays a critical role in the cholesterol biosynthesis pathway, being cholesterol the major sterol component in mammalian membranes as well as a precursor for bile acid and steroid hormone synthesis. Cytochrome P450 monooxygenase that catalyzes the three-step oxidative removal of the 14alpha-methyl group (C-32) of sterols such as lanosterol (lanosta-8,24-dien-3beta-ol) and…. (UniProt, Q16850)
Open in Phaseline: the race on CYP51, likelihood bands and readouts
| Company | Drug | Targets | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|---|
| Urooj Fatima | Fluconazole Cytochrome P450 51 inhibitor | CYP51 | Phase 4 | Tinea Corporis | – |
| Urooj Fatima | Itraconazole Cytochrome P450 51 inhibitor | CYP51 | Phase 4 | Tinea Corporis | – |
Tinea Corporis (2)
small molecule (2)
Urooj Fatima (2)
–
Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.